首页> 外国专利> METHOD OF THROMBOXANE-FORMATION NORMALISATION FOR PATIENTS SUFFERING FORM ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME

METHOD OF THROMBOXANE-FORMATION NORMALISATION FOR PATIENTS SUFFERING FORM ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME

机译:代谢综合征引起的形式性高血压的患者血栓烷形成归一化方法

摘要

FIELD: medicine; cardiology.;SUBSTANCE: in case patient is diagnosed with increased thromboxane development resulted from three transfer tests while level of thrombocyte aggregation restoration within simple transfer test is higher than 37.0%, indicators of collagen-aspirin test are higher than 69.0% and/or of collagen-imidazole test is higher than 59%, for purposes of thromboxane development correction associated with arterial hypertension and metabolic syndrome, low-calorie diet, graduated physical activity, intake of Lovastatin 20 mg for the night and Amlodipine 10 mg once a day are prescribed for patient within 4 months.;EFFECT: provided normalisation of thromboxane formation in thrombocytes.;1 tbl, 3 ex
机译:领域:医学;心脏病学;实质:如果经三次转移试验诊断出患者血栓烷发展增加,而简单转移试验中血小板聚集恢复水平高于37.0%,则胶原阿司匹林试验指标高于69.0%和/或胶原咪唑试验高于59%,用于与动脉高血压和代谢综合征相关的血栓烷发育校正,低热量饮食,渐进体力活动,夜间服用洛伐他汀20毫克和氨氯地平10毫克适用于4个月内的患者;效果:使血小板中血栓烷形成正常化。1tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号